Filing Flows › cbdMD (YCBD) › Q3 FY25
cbdMD (YCBD) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed Aug 14, 2025
cbdMD (YCBD) reported revenue of $4.6M for the third quarter fiscal 2025 (Q3 FY25), -11% from a year earlier and -3% from the quarter before. Operating margin was -19.6%, net loss $895K (19.4% of revenue).
cbdMD, Q3 FY25: revenue $4.6M (-11% year over year), operating margin -19.6%, net loss $895K, operating cash flow −$704K. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.6M | -3% | -11% |
| Operating profit | −$905K | — | — |
| Net earnings | −$895K | — | — |
| Operating cash flow | −$704K | — | — |
What changed
Revenue was $4.6M in Q3 FY25, down 11% year over year and down 3% from the previous quarter.
Gross margin was 61.5%, down 4.3 points from a year earlier. Operating costs exceeded revenue by $905K, an operating margin of -19.6%. Operating expenses fell 1% while revenue fell 11%. The quarter ended with a net loss of $895K, wider than the previous quarter's $481K loss.
Operating cash flow was −$704K. Non-cash charges added back $280K of depreciation and amortization. Working capital and other items used $89K. Capital expenditures of $1K exceeded it, leaving free cash flow of −$706K.
Questions
What was cbdMD's revenue in the third quarter fiscal 2025?
cbdMD (YCBD) reported revenue of $4.6M for the third quarter fiscal 2025 (Q3 FY25), -11% from a year earlier and -3% from the quarter before.
Was cbdMD profitable in the third quarter fiscal 2025?
Operating loss was $905K (-19.6% of revenue) and net loss $895K.
Source: cbdMD 10-Q on SEC EDGAR.